These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29108665)

  • 1. Evaluation of a polyvalent foot-and-mouth disease virus vaccine containing A Saudi-95 against field challenge on large-scale dairy farms in Saudi Arabia with the emerging A/ASIA/G-VII viral lineage.
    Lyons NA; Ludi AB; Wilsden G; Hamblin P; Qasim IA; Gubbins S; King DP
    Vaccine; 2017 Dec; 35(49 Pt B):6850-6857. PubMed ID: 29108665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the performance of foot-and-mouth disease vaccines prepared against local strains in the face of antigenic evolution in the field.
    Tuncer-Göktuna P; Çokçalışkan C; Arslan A; Taşçene N; Uzun EA; Gündüzalp C; Balcı GN; Kara O; Gülyaz V
    Transbound Emerg Dis; 2021 Mar; 68(2):648-655. PubMed ID: 32677765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage.
    Waters R; Ludi AB; Fowler VL; Wilsden G; Browning C; Gubbins S; Statham B; Bin-Tarif A; Mioulet V; King DJ; Colenutt C; Brown E; Hudelet P; King DP
    Vaccine; 2018 Mar; 36(14):1901-1907. PubMed ID: 29506922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Vaccine Based on the A/ASIA/G-VII Lineage of Foot-and-Mouth Disease Virus Offers Low Levels of Protection against Circulating Viruses from the A/ASIA/Iran-05 lineage.
    Singanallur NB; Eblé PL; Ludi AB; Statham B; Bin-Tarif A; King DP; Dekker A; Vosloo W
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological analysis of an outbreak of foot-and-mouth disease (serotype SAT2) on a large dairy farm in Kenya using regular vaccination.
    Lyons NA; Stärk KD; van Maanen C; Thomas SL; Chepkwony EC; Sangula AK; Dulu TD; Fine PE
    Acta Trop; 2015 Mar; 143():103-11. PubMed ID: 25447264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East.
    Mahapatra M; Upadhyaya S; Aviso S; Babu A; Hutchings G; Parida S
    Vaccine; 2017 Dec; 35(51):7147-7153. PubMed ID: 29157957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative characteristics of the foot-and-mouth disease carrier state under natural conditions in India.
    Hayer SS; Ranjan R; Biswal JK; Subramaniam S; Mohapatra JK; Sharma GK; Rout M; Dash BB; Das B; Prusty BR; Sharma AK; Stenfeldt C; Perez A; Rodriguez LL; Pattnaik B; VanderWaal K; Arzt J
    Transbound Emerg Dis; 2018 Feb; 65(1):253-260. PubMed ID: 28251837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epizootiology of foot and mouth disease in Saudi Arabia: II. Current status on dairy farms and control measures in operation.
    Hafez SM; Farag MA; al-Sukayran A
    Rev Sci Tech; 1993 Sep; 12(3):817-30. PubMed ID: 8219331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of doubled dose administration of foot-and-mouth disease vaccine against heterologous virus infection in cattle.
    Kawaguchi R; Nishi T; Fukai K; Ikezawa M; Kokuho T; Morioka K
    J Vet Med Sci; 2024 Jul; 86(7):777-786. PubMed ID: 38719616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foot-and-mouth disease virus O/ME-SA/Ind 2001 lineage outbreak in vaccinated Holstein Friesian cattle in Saudi Arabia in 2016.
    Hemida MG; Rizk El-Ghareeb W; Al-Hizab F; Ibrahim A
    Vet Q; 2018 Dec; 38(1):88-98. PubMed ID: 30706772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2014 Apr; 32(16):1848-55. PubMed ID: 24530150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of foot and mouth disease (FMD) vaccine using registered surveillance data.
    Emami SJ; Bahonar AR; Mehrabadi MHF; Lotfollazadeh S; Amiri K; Abdollahi D
    Trop Anim Health Prod; 2022 Jun; 54(4):215. PubMed ID: 35723776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain.
    Lloyd-Jones K; Mahapatra M; Upadhyaya S; Paton DJ; Babu A; Hutchings G; Parida S
    Vaccine; 2017 Dec; 35(49 Pt B):6842-6849. PubMed ID: 29102329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for design and implementation of vaccine field trials for novel foot-and-mouth disease vaccines.
    Lyons NA; Knight-Jones TJD; Bartels C; Paton DJ; Ferrari G; Vermillion MS; Brooks AW; Motroni R; Parker E; Hefferin Berquist ML; Sumption KJ; Klement E
    Vaccine; 2019 Feb; 37(8):1007-1015. PubMed ID: 30685245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the level of herd infection for outbreaks of foot-and-mouth disease in vaccinated herds.
    Hutber AM; Kitching RP; Conway DA
    Epidemiol Infect; 1999 Jun; 122(3):539-44. PubMed ID: 10459659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of vaccination to prevent outbreaks of foot-and-mouth disease.
    Woolhouse ME; Haydon DT; Pearson A; Kitching RP
    Epidemiol Infect; 1996 Jun; 116(3):363-71. PubMed ID: 8666082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E; Li Y; Zamir L; Even-Tov B; Hamblin P; Gelman B; Hammond J; Klement E
    Vaccine; 2013 Jan; 31(6):879-85. PubMed ID: 23246551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region.
    Maradei E; Malirat V; Beascoechea CP; Benitez EO; Pedemonte A; Seki C; Novo SG; Balette CI; D'Aloia R; La Torre JL; Mattion N; Toledo JR; Bergmann IE
    Vet Microbiol; 2013 Mar; 162(2-4):479-490. PubMed ID: 23182909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.